# Trial of Endostar Combined With CHOPT for T Cell Lymphoma

> **NCT01430013** · PHASE2 · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 30 (estimated)

## Conditions studied

- T Cell Lymphoma

## Interventions

- **DRUG:** Endostar and CHOPT

## Key facts

- **NCT ID:** NCT01430013
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01430013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01430013, "Trial of Endostar Combined With CHOPT for T Cell Lymphoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01430013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*